Hosted on MSN10mon
BRD7 research points to alternative insulin signaling pathwayNow, Boston Children's Division of Endocrinology researchers have discovered another purpose for BRD7: It seems to be involved in an alternative insulin signaling pathway, the existence of which ...
Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the ...
The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.
8d
StudyFinds on MSNThe critical ‘window’ in midlife for slowing down brain agingBrain aging follows a surprising trajectory with a potentially game-changing discovery: there appears to be a crucial "window ...
Studies have shown that during the development of insulin resistance, many steps in the metabolic pathway activated by insulin are altered. However, much less attention has so far been paid to ...
disrupts the effect of insulin on the endothelium of blood vessels, leading to insulin resistance linked to obesity and type 2 diabetes. The clue to this discovery lies in a molecular pathway that ...
FDA is in the process of revising as part of that some of the rules to make it a smoother, easier path for another company to come in and say, "Well, my insulin product is close enough to the ...
Researchers have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity - a harmful condition linked to the progression of type 2 ...
Though insulin was the starting point, it was only the first step on our path to better support people with diabetes. Since partnering with Sanofi, GoodRx broadened its efforts by launching cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results